Disease Info Card

Hyperlipoproteinemia Type Iib

Information about Hyperlipoproteinemia Type Iib: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hyperlipoproteinemia Type Iib

Most recent studies have shown that Hyperlipoproteinemia Type Iib shares some biological mechanisms with arteriosclerosis, atherosclerosis, cardiovascular-diseases, coronary-artery-disease, coronary-heart-disease, familial-hypercholesterolemia---heterozygous, familial-hypercholesterolemia---homozygous, heart-diseases, hereditary-diseases, hypercholesterolemia, hypercholesterolemia-familial, hyperlipidemia, hyperlipidemia-familial-combined, hyperlipoproteinemia-type-iv, hyperlipoproteinemias, infarction, myocardial-infarction, myocardial-ischemia, xanthoma, xanthomatosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hyperlipoproteinemia Type Iib, and have been seen in publications frequently: Cell Adhesion, Cell Proliferation, Cholesterol Efflux, Cholesterol Esterification, Cholesterol Homeostasis, Cholesterol Transport, Coagulation, Endocytosis, Excretion, Fibrinolysis, Localization, Pathogenesis, Platelet Aggregation, Receptor-mediated Endocytosis, Response To Statin, Reverse Cholesterol Transport, Secretion, Translation, Transport, Vasodilation

Quite a number of genes have been found to play important roles in Hyperlipoproteinemia Type Iib, such as APOA1, APOB, APOE, CD55, CETP, CFH, CRP, FH, HMGCR, INS, LDLR, LPA, LPL, PCSK9, SEPSECS, TCN2, TG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.